Affymax's(NASDAQOTH:AFFY)

In this video, health care analysts Max Macaluso and David Williamson look at Affymax's recent rise and discuss the importance of Omontys' sales to the future of this stock.

Affymax is on a great run this week, but it wasn't selected as The Motley Fool's Top Stock for 2012. In this special report, our chief investment officer identifies his favorite company for the year. To read this report before the rest of the market catches on, click here -- it's absolutely free.